IP Library Patent Application 17538166
Patent Application
App. No. 17/538,166

gRNA STABILIZATION IN NUCLEIC ACID-GUIDED NICKASE EDITING

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
17/538,166
Abstract

The present disclosure provides compositions of matter, methods and instruments for nucleic acid-guided nickase/reverse transcriptase fusion editing in live cells. Editing efficiency is improved using fusion proteins (e.g., the nickase-RT fusion) that retain certain characteristics of nucleic acid-directed nucleases (e.g., the binding specificity and ability to cleave one or more DNA strands in a targeted manner) combined with reverse transcriptase activity. Editing cassettes are employed, comprising a gRNA and a repair template where the 3′ end of the repair template is protected from degradation.

Claims (28)

1 . A CREATE fusion editing cassette for performing nucleic acid-guided nickase/reverse transcriptase fusion editing comprising from 3′ to 5′:

an RNA repair template comprising:

an RNA stabilization moiety;

a linker region;

a primer binding region capable of binding to a nicked target DNA;

a nick-to-edit region; and

a region of post-edit homology;

a gRNA comprising:

a guide sequence; and

a scaffold region.

2 . The CREATE fusion editing cassette of claim 1 , wherein the RNA stabilization moiety is a G quadraplex, an RNA hairpin, an RNA pseudoknot or an exoribonuclease resistant RNA.

3 . The CREATE fusion editing cassette of claim 2 , wherein the RNA stabilization moiety is a G quadraplex.

4 . The CREATE fusion editing cassette of claim 3 , wherein the RNA stabilization moiety is a G quadraplex selected from SEQ ID No: 1; SEQ ID No: 2; SEQ ID No: 3; SEQ ID No: 4; SEQ ID No: 5; SEQ ID No: 6; SEQ ID No: 7; SEQ ID No: 8; SEQ ID No: 9; and SEQ ID No: 10.

5 . The CREATE fusion editing cassette of claim 3 , wherein the RNA stabilization moiety is a G quadraplex selected from SEQ ID No: 11; SEQ ID No: 12; SEQ ID No: 13; SEQ ID No: 14; SEQ ID No: 15; SEQ ID No: 16; SEQ ID No: 17; SEQ ID No: 18; SEQ ID No: 19; and SEQ ID No: 20.

6 . The CREATE fusion editing cassette of claim 3 , wherein the RNA stabilization moiety is a G quadraplex selected from SEQ ID No: 21; SEQ ID No: 22; SEQ ID No: 23; SEQ ID No: 24; SEQ ID No: 25; SEQ ID No: 26; SEQ ID No: 27; SEQ ID No: 28; SEQ ID No: 29; and SEQ ID No: 30.

7 . The CREATE fusion editing cassette of claim 3 , wherein the RNA stabilization moiety is a G quadraplex selected from SEQ ID No: 31; SEQ ID No: 32; SEQ ID No: 33; SEQ ID No: 34; SEQ ID No: 35; SEQ ID No: 36; SEQ ID No: 37; SEQ ID No: 38; SEQ ID No: 39; and SEQ ID No: 40.

8 . The CREATE fusion editing cassette of claim 3 , wherein the RNA stabilization moiety is a G quadraplex selected from SEQ ID No: 41; SEQ ID No: 42; SEQ ID No: 43; SEQ ID No: 44; SEQ ID No: 45; SEQ ID No: 46; SEQ ID No: 47; SEQ ID No: 48; and SEQ ID No: 29.

9 . The CREATE fusion editing cassette of claim 2 , wherein the RNA stabilization moiety is an RNA hairpin.

10 . The CREATE fusion editing cassette of claim 9 , wherein the RNA stabilization moiety is an RNA hairpin selected from SEQ ID No: 50; SEQ ID No: 51; SEQ ID No: 52; SEQ ID No: 53; SEQ ID No: 54; SEQ ID No: 55; SEQ ID No: 65; SEQ ID No: 66; SEQ ID No: 67; SEQ ID No: 68; SEQ ID No: 69; and SEQ ID No: 70.

11 . The CREATE fusion editing cassette of claim 2 , wherein the RNA stabilization moiety is an RNA pseudoknot.

12 . CREATE fusion editing cassette of claim 11 , wherein the RNA stabilization moiety is an RNA pseudoknot selected from SEQ ID No: 50; SEQ ID No: 56; SEQ ID No: 57; SEQ ID No: 58; SEQ ID No: 59; SEQ ID No: 60; SEQ ID No: 61; SEQ ID No: 62; SEQ ID No: 63; and SEQ ID No: 64.

13 . The CREATE fusion editing cassette of claim 2 , wherein the RNA stabilization moiety is an exoribonuclease resistant RNA.

14 . The CREATE fusion editing cassette of claim 13 , wherein the RNA stabilization moiety is an exoribonuclease resistant RNA selected from SEQ ID No: 71; SEQ ID No: 72; and SEQ ID No: 73.

15 . The CREATE fusion editing cassette of claim 1 , wherein the linker region is from 0 to 20 nucleotides in length.

16 . The CREATE fusion editing cassette of claim 1 , wherein the primer binding region is from 0 to 20 nucleotides in length.

17 . The CREATE fusion editing cassette of claim 1 , wherein the nick-to-edit region is from 0 to 20 nucleotides in length.

18 . The CREATE fusion editing cassette of claim 1 , wherein the region of post-edit homology is 3 to 20 nucleotides in length.

19 . The CREATE fusion editing cassette of claim 1 , wherein the guide sequence of the gRNA is capable of hybridizing to a genomic target locus and wherein the scaffold sequence of the gRNA is capable of interacting or complexing with a nucleic acid-guided nuclease.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 15, 2022
From: MIR, AAMIR
To: INSCRIPTA, INC.
Reel/Frame 058667/0409 →